Description

Description

Galza-Met (50/850mg) is a fixed-dose combination tablet formulated for adults living with Type 2 Diabetes Mellitus who require more than one active substance to keep their blood sugar within a healthy range. Each pack contains 14 tablets, offering a two-week supply for patients following a prescribed treatment schedule. The formulation brings together Vildagliptin, a DPP-4 inhibitor, and Metformin Hydrochloride, a biguanide-class agent, into a single tablet. This pairing is widely used in diabetes care because the two molecules work through different but complementary mechanisms, helping patients who are not achieving adequate glycemic control on Metformin alone. Galza-Met is intended to be used strictly under medical supervision and forms part of a broader diabetes management plan that typically also includes dietary control, regular physical activity, and routine blood sugar monitoring.

Ingredients

Each Galza-Met (50/850mg) tablet contains two active pharmaceutical ingredients: Vildagliptin 50mg and Metformin Hydrochloride 850mg. Vildagliptin works by inhibiting the DPP-4 enzyme, which in turn helps the body maintain higher levels of active incretin hormones that stimulate insulin release when blood sugar is elevated. Metformin Hydrochloride reduces the amount of glucose produced by the liver and improves how the body’s tissues respond to insulin. Alongside these active components, the tablet also contains standard pharmaceutical excipients such as binders, fillers, and coating agents that help maintain tablet stability, appearance, and shelf life. The exact excipient composition may vary slightly by manufacturing batch, so patients with known excipient sensitivities should review the packaging insert or consult their pharmacist.

Dosage Form

Galza-Met is manufactured as a film-coated oral tablet. Each strip or box typically contains 14 tablets, making it convenient for short-term prescription cycles or trial periods before a doctor adjusts the treatment plan. The tablets are designed for oral administration only and should not be crushed, split, or chewed unless specifically advised by a healthcare provider.

Uses

Galza-Met (50/850mg) is primarily prescribed for the management of Type 2 Diabetes Mellitus in adults. It is generally used when diet and exercise alone, or Metformin monotherapy alone, have not provided sufficient blood sugar control. By combining two complementary mechanisms of action, this tablet helps support more stable fasting and post-meal glucose levels. It may also be prescribed as an add-on therapy alongside other antidiabetic medications, depending on the individual patient’s condition, medical history, and response to earlier treatments, as determined by a qualified physician.

How to Use

Galza-Met should only be taken exactly as prescribed by a registered physician. It is commonly taken with meals to help reduce the likelihood of stomach discomfort associated with Metformin. Tablets should be swallowed whole with a glass of water, without crushing or chewing. Patients should never adjust the dose, frequency, or duration of use on their own, and should not stop the medication abruptly without medical advice, even if blood sugar levels appear to improve. Missing a dose should be handled according to the doctor’s specific instructions rather than doubling up the next dose.

Side Effects

As with any medication, Galza-Met may cause side effects in some individuals, though not everyone experiences them. Commonly reported effects include nausea, mild stomach upset, diarrhea, loss of appetite, dizziness, or headache, particularly when treatment is first started. Less commonly, patients may experience symptoms of low blood sugar (hypoglycemia) such as sweating, shakiness, or confusion, especially if combined with other diabetes medications. Rare but serious reactions may include signs of liver dysfunction, severe allergic reactions, or lactic acidosis (a rare but serious metabolic complication linked to Metformin). Any unusual, persistent, or severe symptoms should be reported to a doctor immediately.

Pregnancy & Breastfeeding

The use of Galza-Met during pregnancy and breastfeeding has not been established as fully safe and should only be considered under strict medical guidance. Women who are pregnant, planning a pregnancy, or breastfeeding should inform their doctor before starting this medication, as alternative treatment approaches, such as insulin therapy, may be preferred during these periods. This medication should never be self-prescribed or continued without ongoing medical supervision in such circumstances.

Storage Instructions

Galza-Met tablets should be stored in a cool, dry place, away from direct sunlight and moisture, ideally at room temperature as indicated on the product packaging. Keep the medication in its original blister pack or container until it is time to take a dose, and ensure it is stored out of reach of children and pets. Do not use the tablets beyond the expiry date printed on the packaging, and dispose of any expired or unused medication responsibly, following local pharmaceutical disposal guidelines.

FAQS

Can I take Galza-Met without a prescription?
No, this is a prescription medicine and should only be used under the guidance of a qualified doctor.

What should I do if I miss a dose?
Follow your doctor’s specific instructions; do not take a double dose to make up for a missed one.

Can Galza-Met be taken with other diabetes medicines?
It may be combined with other treatments in some cases, but only if advised by your physician.

Does this medicine cure diabetes?
No, it helps manage blood sugar levels as part of an ongoing treatment plan; it does not cure diabetes.

Is it safe for long-term use?
Many patients use similar combinations long-term under medical supervision, with periodic monitoring of kidney and liver function.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.